Navigation Links
TruFUSE(R) Patents Awarded
Date:7/8/2008

CLEARWATER, Fla., July 8 /PRNewswire/ -- minSURG(TM) Corporation, through its parent company, Orthopedic Development Corporation, has received a Notice of Allowance from the United States Patent and Trademark Office on two of its pending US patent applications. The patents protect the designs of one of its TruFUSE(R) dowels and a Surgical Drill Guide, which is used in minSURG's proprietary TruFUSE Minimally Invasive Facet Fusion Procedures and Systems. The pending patents, once issued, will offer patent protection through 2022.

Six additional patent applications related to the TruFUSE product remain pending. TruFUSE uses specially designed bone dowels to stop facet joints from moving, which is intended to eliminate or dramatically reduce back pain caused by a variety of reasons. TruFUSE is also used to supplement other back surgeries when more invasive or destructive means are not required. The TruFUSE procedure is intended to fuse the facet joints through a natural healing process for a long-term solution. Because TruFUSE causes minimal tissue damage, it does not preclude other options, including non-surgical alternatives, and TruFUSE can be used earlier than other, more invasive spine fusion methods.

For more information on TruFUSE, please visit the Web site at http://www.trufuse.com or call (813) 318-0565 ext. 216.


'/>"/>
SOURCE minSURG(TM) Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
2. Over 600 Surgeons Certified to use TruFUSE(R) to Treat Back Pain Sufferers
3. TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels
4. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
5. Cyberonics Licenses Obesity-Related Patents
6. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
7. The Quantum Group Files Four Additional Patents
8. Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products
9. Telik Announces Patents on Compounds Related to TELINTRA
10. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
11. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... Researchers at Johns Hopkins All Children’s Hospital want to learn ... the course of three years, researchers will study concussions and changes in brain function ... with special sensors, will track the location and force of the hit. The sensors ...
(Date:12/5/2016)... ... 05, 2016 , ... “Epilepsy Awareness,” which can be found ... a conversation about epilepsy, bearing down on the social stigma and lack of ... with epilepsy within their lifetime. With such a large percentage of people affected, ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus on ... PER® president, Phil Talamo said, “We are honored to have Amy E. Herman ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... geographic lines. The goal of Castlewood Treatment Centers has always been to promote ... to as many people as possible. In that spirit, Castlewood has announced two ...
(Date:12/5/2016)... , ... December 05, 2016 , ... Dr. Barry M. ... Cosmetic Plastic Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium ... the newest techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: